Appetite hormones, neuropsychological function and methylphenidate use in children with
Kuan-Yu Lai1, Chia-Jung Li1, Ching-Shu Tsai1
1Department of Child and Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Insights
Appetite hormones like orexin A and leptin are linked to attention deficit/hyperactivity disorder (ADHD) pathophysiology. Ghrelin influences attention and methylphenidate treatment effectiveness and side effects in ADHD patients.
Area of Science:
- Neuroendocrinology
- Neuropsychiatry
- Pharmacology
Background:
- Appetite hormones influence neuronal excitability, synaptic plasticity, and brain development.
- Attention deficit/hyperactivity disorder (ADHD) involves complex neurobiological mechanisms.
- Understanding appetite hormone roles in ADHD may illuminate pathophysiology and treatment.
Purpose of the Study:
- To investigate the role of appetite hormones (orexin A, ghrelin, leptin, adiponectin) in ADHD.
- To explore associations between these hormones and ADHD pathophysiology, methylphenidate treatment, and side effects.
Main Methods:
- Serum levels of orexin A, ghrelin, leptin, and adiponectin were measured in 119 ADHD patients on methylphenidate (ADHD+MPH), 77 unmedicated ADHD patients (ADHD-MPH), and 87 controls.
- Behavioral symptoms and attention were assessed using rating scales and neuropsychological tests.
- Methylphenidate side effects were evaluated using a standardized scale.
Main Results:
- Orexin A levels were lower in both ADHD groups compared to controls, and lower in ADHD+MPH than ADHD-MPH.
- Leptin levels were significantly lower in both ADHD groups than in controls.
- Ghrelin levels positively correlated with auditory attention, methylphenidate dosage, and negatively with side effects in the ADHD+MPH group.
Conclusions:
- Orexin A and leptin are implicated in the etiology of ADHD.
- Orexin A and ghrelin are important in attention deficits and response to methylphenidate treatment in ADHD.
- Appetite hormones offer potential biomarkers and therapeutic targets for ADHD.
Abstract:
Appetite hormones may play a significant role in neuronal excitability and synaptic plasticity and may also affect brain function development. This study aimed to explore the role of appetite hormones in attention deficit/hyperactivity disorder (ADHD), including aspects of pathophysiology, pharmacotherapy, and side effects. We recruited 119 patients with ADHD who were undergoing methylphenidate treatment (ADHD+MPH), 77 unmedicated ADHD patients (ADHD-MPH), and 87 healthy controls. Blood samples were collected from all participants to examine serum levels of orexin A, ghrelin, leptin, and adiponectin. Behavioral symptoms were assessed using the Swanson, Nolan, and Pelham Rating Scale, and visual and auditory attention were evaluated using computerized neuropsychological tests. The side effects of methylphenidate treatment were measured using Barkley's Side Effects Rating Scale. Orexin levels in the control group were significantly higher than in the ADHD-MPH (p=0.037) and ADHD+MPH (p<0.001) groups; additionally, orexin levels in the ADHD-MPH group were significantly higher than in the ADHD+MPH group (p=0.032). Leptin levels in both the ADHD+MPH (p=0.011) and ADHD-MPH (p=0.011) groups were significantly lower than in the control group. Ghrelin levels were positively associated with auditory attention across all ADHD groups (p=0.015). Furthermore, ghrelin levels were positively correlated with methylphenidate dosage (p=0.024), and negatively correlated with methylphenidate side effects (p=0.044) in the ADHD+MPH group. These findings provide further insight into the relationships between appetite hormones, pharmacotherapy, and ADHD. Orexin A and leptin are associated with the etiology of ADHD, while orexin A and ghrelin play important roles in attention deficits and methylphenidate usage in ADHD.
More Related Videos
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Regulation of Food Intake
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Affecting Neurotransmitter Synthesis
